Orion Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-200
| Closed | -$22.5K | – | 513 |
|
|
2023
Q3 | $22.5K | Buy |
+200
| New | +$22.5K | 0.01% | 306 |
|
|
2023
Q2 | – | Sell |
-200
| Closed | -$20.2K | – | 315 |
|
|
2023
Q1 | $20.2K | Sell |
200
-100
| -33% | -$10.1K | 0.01% | 309 |
|
|
2022
Q4 | $35.8K | Hold |
300
| – | – | 0.03% | 223 |
|
|
2022
Q3 | $32K | Sell |
300
-100
| -25% | -$10.7K | 0.03% | 235 |
|
|
2022
Q2 | $39K | Hold |
400
| – | – | 0.03% | 214 |
|
|
2022
Q1 | $38K | Hold |
400
| – | – | 0.02% | 225 |
|
|
2021
Q4 | $34K | Buy |
+400
| New | +$34K | 0.02% | 222 |
|